Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Radiotherapy of bladder cancer].
Riou O, Chauvet B, Lagrange JL, Martin P, Llacer Moscardo C, Charissoux M, Lauche O, Aillères N, Fenoglietto P, Azria D. Riou O, et al. Among authors: lauche o. Cancer Radiother. 2016 Sep;20 Suppl:S196-9. doi: 10.1016/j.canrad.2016.07.010. Epub 2016 Aug 9. Cancer Radiother. 2016. PMID: 27521030 French.
[Radiosensitivity settings in breast cancer].
Lauche O, Azria D, Riou O, Charissoux M, Lemanski C, Bourgier C. Lauche O, et al. Cancer Radiother. 2015 Jun;19(4):237-40. doi: 10.1016/j.canrad.2015.04.001. Epub 2015 May 23. Cancer Radiother. 2015. PMID: 26006764 French.
[RHESOU (Registry in HErault Specialized in Onco-Urology) : the first French Registry specialized in Onco-Urology. One-year experience].
Trouche-Sabatier SG, Rebillard X, Iborra F, Azria D, Daures JP, Poinas G, Abdo N, Delbos O, Gevorgyan A, Marchal S, Guillon R, Millet I, Lamy PJ, Lauche O, Reis-Borges R, Serre I, Topart D, Tretarre B; tous les acteurs de l’onco-urologie de l’Hérault. Trouche-Sabatier SG, et al. Among authors: lauche o. Prog Urol. 2020 Dec;30(16):1038-1044. doi: 10.1016/j.purol.2020.09.015. Epub 2020 Oct 1. Prog Urol. 2020. PMID: 33012630 French.
Single-fraction high-dose-rate brachytherapy using real-time transrectal ultrasound based planning in combination with external beam radiotherapy for prostate cancer: dosimetrics and early clinical results.
Lauche O, Delouya G, Taussky D, Menard C, Béliveau-Nadeau D, Hervieux Y, Larouche R, Barkati M. Lauche O, et al. J Contemp Brachytherapy. 2016 Apr;8(2):104-9. doi: 10.5114/jcb.2016.59216. Epub 2016 Apr 14. J Contemp Brachytherapy. 2016. PMID: 27257413 Free PMC article.
Cemiplimab for Locally Advanced and Metastatic Cutaneous Squamous-Cell Carcinomas: Real-Life Experience from the French CAREPI Study Group.
Hober C, Fredeau L, Pham-Ledard A, Boubaya M, Herms F, Celerier P, Aubin F, Beneton N, Dinulescu M, Jannic A, Meyer N, Duval-Modeste AB, Cesaire L, Neidhardt ÈM, Archier É, Dréno B, Lesage C, Berthin C, Kramkimel N, Grange F, de Quatrebarbes J, Stoebner PE, Poulalhon N, Arnault JP, Abed S, Bonniaud B, Darras S, Heidelberger V, Devaux S, Moncourier M, Misery L, Mansard S, Etienne M, Brunet-Possenti F, Jacobzone C, Lesbazeilles R, Skowron F, Sanchez J, Catala S, Samimi M, Tazi Y, Spaeth D, Gaudy-Marqueste C, Collard O, Triller R, Pracht M, Dumas M, Peuvrel L, Combe P, Lauche O, Guillet P, Reguerre Y, Kupfer-Bessaguet I, Solub D, Schoeffler A, Bedane C, Quéreux G, Dalac S, Mortier L, Maubec È. Hober C, et al. Among authors: lauche o. Cancers (Basel). 2021 Jul 15;13(14):3547. doi: 10.3390/cancers13143547. Cancers (Basel). 2021. PMID: 34298764 Free PMC article.
Duration of treatment with cemiplimab in advanced cutaneous squamous cell carcinoma in complete response: Real-life study.
Khelef K, Maubec E, Jeudy G, Bonniaud B, Pham-Ledard A, Herms F, Aubin F, Beneton N, Dinulescu M, Jannic A, Duval-Modeste A, Archier E, Berthin C, Grange F, Arnault J, Heidelberger V, Moncourier M, Mansard S, Brunet-Possenti F, Triller R, Pracht M, Dumas M, Lauche O, Mortier L, Bedane C, Dalac Rat S. Khelef K, et al. Among authors: lauche o. J Eur Acad Dermatol Venereol. 2024 Jan;38(1):e71-e73. doi: 10.1111/jdv.19435. Epub 2023 Sep 23. J Eur Acad Dermatol Venereol. 2024. PMID: 37595320 No abstract available.